These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23979523)
1. Epigenetic mechanisms of protein tyrosine phosphatase 6 suppression in diffuse large B-cell lymphoma: implications for epigenetic therapy. Witzig TE; Hu G; Offer SM; Wellik LE; Han JJ; Stenson MJ; Dogan A; Diasio RB; Gupta M Leukemia; 2014 Jan; 28(1):147-54. PubMed ID: 23979523 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL. Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513 [TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter 2 methylation‑mediated downregulation of protein tyrosine phosphatase, non‑receptor type 6, is associated with progression of esophageal squamous cell carcinoma. Liu L; Zhang S; Liu X; Liu J Mol Med Rep; 2019 Apr; 19(4):3273-3282. PubMed ID: 30816454 [TBL] [Abstract][Full Text] [Related]
4. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia. Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneous epigenetic regulation of TIMP3 in prostate cancer. Shinojima T; Yu Q; Huang SK; Li M; Mizuno R; Liu ET; Hoon DS; Lessard L Epigenetics; 2012 Nov; 7(11):1279-89. PubMed ID: 23023649 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203 [TBL] [Abstract][Full Text] [Related]
7. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation. Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198 [TBL] [Abstract][Full Text] [Related]
8. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758 [TBL] [Abstract][Full Text] [Related]
9. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases. Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma. Cycon KA; Mulvaney K; Rimsza LM; Persky D; Murphy SP Immunology; 2013 Oct; 140(2):259-72. PubMed ID: 23789844 [TBL] [Abstract][Full Text] [Related]
12. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma. Demosthenous C; Han JJ; Hu G; Stenson M; Gupta M Oncotarget; 2015 Dec; 6(42):44703-13. PubMed ID: 26565811 [TBL] [Abstract][Full Text] [Related]
13. [Significance of expression and promoter methylation of LITAF gene in B-cell lymphoma]. Wang J; Shi Y; Wang L; Ren G; Bai Y; Shi H; Zhang X; Jiang X; Zhou R Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):516-21. PubMed ID: 25346120 [TBL] [Abstract][Full Text] [Related]
15. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines. Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686 [TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
17. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159 [TBL] [Abstract][Full Text] [Related]
18. Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma. Zhang YW; Zhang J; Li J; Zhu JF; Yang YL; Zhou LL; Hu ZL; Zhang F Leuk Lymphoma; 2015; 56(8):2429-38. PubMed ID: 25487076 [TBL] [Abstract][Full Text] [Related]
19. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. Mossman D; Kim KT; Scott RJ BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma. Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]